Source: Pharmabiz

Ab Initio: RespireRx Pharmaceuticals' arm ResolutionRx inks agreement with Ab Initio for manufacturing of dronabinol

RespireRx (formerly known as Cortex Pharmaceuticals, Inc.) Pharmaceuticals Inc., focused on the discovery and development of innovative and revolutionary treatments to combat diseases caused by

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
500-1.0K
CEO Avatar

Founder & CEO

Sheryl Handler

CEO Approval Rating

58/100

Read more